Next |
home / stock / achff / achff message board
Subject | By | Source | When |
---|---|---|---|
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 04/30/2023 9:23:37 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 04/15/2023 3:40:59 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/27/2023 1:03:03 AM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/21/2023 11:01:09 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/05/2023 11:11:11 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 12/18/2022 10:26:04 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 10/23/2022 5:28:14 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 08/31/2022 10:07:29 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 07/17/2022 10:02:49 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 06/06/2022 5:16:15 AM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 06/04/2022 6:59:28 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 05/01/2022 5:35:53 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 03/12/2022 7:33:49 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 02/05/2022 11:01:29 PM |
https://www.otcmarkets.com/stock/$ACHFF | mick | investorshub | 01/02/2022 10:54:56 PM |
https://www.otcmarkets.com/stock/$ACHFF | mick | investorshub | 12/11/2021 10:36:57 PM |
whytestocks: $ACHFF News Article - Arch Biopartners' Lead Drug LSALT Peptide to Enter the Canadian T | whytestocks | investorshangout | 12/01/2021 3:15:53 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 11/07/2021 6:09:07 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 11/06/2021 4:16:26 PM |
PhaseII Clinical trail Data locked end June, | dayneyus | investorshub | 10/05/2021 4:25:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Arch Biopartners Inc Company Name:
ACHFF Stock Symbol:
OTCMKTS Market:
Arch Biopartners Inc Website:
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II tria...
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Anesthesia Clinical Trials Unit (ACTU), an academic research organization in the Department of Anesthesia and Pa...
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevent...